Publication:
Real-World clinical outcomes of concurrent chemotherapy and dose-escalated twice-daily radiotherapy with simultaneous integrated boost (sib) for limited-stage small cell lung cancer

dc.contributor.coauthorDuman, M.
dc.contributor.coauthorOymak, S. E.
dc.contributor.coauthorKanitez, M.
dc.contributor.coauthorKaban, K.
dc.contributor.coauthorCesur, E.
dc.contributor.coauthorGumus, T.
dc.contributor.coauthorDemirkurek, C.
dc.contributor.departmentSchool of Medicine
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.kuauthorŞenyürek, Şükran
dc.contributor.kuauthorSezen, Duygu
dc.contributor.kuauthorDurankuş, Nilüfer Kılıç
dc.contributor.kuauthorRustamov, Aladin
dc.contributor.kuauthorNasir, Abdullah
dc.contributor.kuauthorGüçlü, Sena Birsen
dc.contributor.kuauthorYumuk, Perran Fulden
dc.contributor.kuauthorSelçukbiricik, Fatih
dc.contributor.kuauthorMandel, Nil Molinas
dc.contributor.kuauthorErus, Suat
dc.contributor.kuauthorTanju, Serhan
dc.contributor.kuauthorDilege, Şükrü
dc.contributor.kuauthorAtasoy, Kayhan Çetin
dc.contributor.kuauthorFalay, Fikri Okan
dc.contributor.kuauthorDemirkol, Mehmet Onur
dc.contributor.kuauthorBulutay, Pınar
dc.contributor.kuauthorFırat, Pınar Arıkan
dc.contributor.kuauthorAtagün, Yasemin
dc.contributor.kuauthorSelek, Uğur
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2026-09-09T13:52:19Z
dc.date.issued2026
dc.description.harvestedfromManual
dc.description.indexedbyScopus
dc.description.indexedbyWoS
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublished Version
dc.identifier.doi10.1016/j.clc.2026.03.010
dc.identifier.eissn1938-0690
dc.identifier.embargoN/A
dc.identifier.endpage131
dc.identifier.grantnoN/A
dc.identifier.issn1525-7304
dc.identifier.issue4
dc.identifier.scopus2-s2.0-105036502611
dc.identifier.startpage123
dc.identifier.urihttp://dx.doi.org/10.1016/j.clc.2026.03.010
dc.identifier.urihttps://hdl.handle.net/20.500.14288/35063
dc.identifier.volume27
dc.identifier.wosWOS:001766014600001
dc.keywordsDose escalation
dc.keywordsLimited-stage disease
dc.keywordsThoracic radiotherapy
dc.keywordsToxicity
dc.keywordsSurvival
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofClinical Lung Cancer
dc.subjectMedicine
dc.subjectOncology
dc.titleReal-World clinical outcomes of concurrent chemotherapy and dose-escalated twice-daily radiotherapy with simultaneous integrated boost (sib) for limited-stage small cell lung cancer
dc.typeJournal Article
dspace.entity.typePublication
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files